Clinical Trial Update: Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse [Phase 2]

View source ↗

Summary

Phase 2 trial of Taxol (paclitaxel) as monotherapy or in combination with topotecan or carboplatin for epithelial ovarian cancer in early relapse has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Malignant Tumor of Peritoneum
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Taxol (paclitaxel)
• Topotecan (topotecan)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED